The authors look at challenges and considerations to continuously improve inspection efficiency.
Peter Kitz
Advertisement
Peter Kitz is vice-president, Global Pharmaceutical Quality, Bristol-Myers Squibb.
Articles by Peter Kitz
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has conducted an annual survey of GMP/GDP inspections at sites and affiliates among its member companies from 2003 until the present time. This article describes findings of the EFPIA annual survey of site inspections among its member companies.
Advertisement
Latest Updated Articles
The GMP/GDP Inspection Landscape—Part I: DataPublished: January 2nd 2017 | Updated:
The GMP/GDP Inspections Landscape—Part II: Considerations and OpportunitiesPublished: February 2nd 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
